Outset Medical Inc (OM)
3.14
+0.14
(+4.67%)
USD |
NASDAQ |
May 03, 16:00
3.135
0.00 (0.00%)
After-Hours: 20:00
Outset Medical Research and Development Expense (Annual): 57.31M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.31M |
| December 31, 2022 | 48.86M |
| December 31, 2021 | 36.74M |
| Date | Value |
|---|---|
| December 31, 2020 | 28.85M |
| December 31, 2019 | 23.33M |
| December 31, 2018 | 22.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
23.33M
Minimum
2019
57.31M
Maximum
2023
39.02M
Average
36.74M
Median
2021
Research and Development Expense (Annual) Benchmarks
| AngioDynamics Inc | 29.88M |
| Baxter International Inc | 667.00M |
| Allurion Technologies Inc | 27.69M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |